Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Rogério Hoefler

Biographic Data

ID1780227
NAMERogério Hoefler
GIVEN NAMESRogério
FAMILY NAMEHoefler
SIGNATUREHOEFLER R
AFFILIATIONSUniversidade de Brasília, Brazil; Conselho Federal de Farmácia, Brasil
ORCID0000-0003-3851-7833
VERIFIEDYes
TOTAL WORKS3
TOTAL CITATIONS0
AUTHOR COUNT3
EDITOR COUNT0
FIRST PUBLICATION YEAR2000
LATEST PUBLICATION YEAR2019
H-INDEX0
  • Added therapeutic value of new drugs approved in Brazil from 2004 to 2016

    Open Access•Rogério Hoefler, Teresa Leonardo Alves et al.•ARTICLE•Cadernos de Saude Publica•2019•References: 18

    This study aimed to assess the level of therapeutic innovation of new drugs approved in Brazil over 13 years and whether they met public health needs. Comparative descriptive analysis of therapeutic value assessments performed by the Brazilian Chamber of Drug Market Regulation (CMED) and the French drug bulletin Prescrire for new drugs licensed in Brazil, from January 1st 2004 to December 31st 2016. The extent to which new drugs met public health…

  • P1-282 Sublingual misoprostol for preventing postpartum haemorrhage: A systematic review

    Rogério Hoefler, M Silva et al.•ARTICLE•Journal of Epidemiology and…•2011

    Objective To assess the efficacy and safety of sublingual misoprostol for preventing postpartum haemorrhage. Method MEDLINE, Embase, CRD, CENTRAL, mRCT, LILACS, SciELO, ProQuest and ISI Web of Knowledge databases were searched. There were no language, accessibility, or publication date restrictions. Randomised clinical trials of sublingual misoprostol in comparison with placebo or other uterotonics were eligible. The primary outcome was postpartu…

  • Sistema Brasileiro de Informação sobre Medicamentos - Sismed

    Open Access•Carlos C F Vidotti, Rogério Hoefler et al.•ARTICLE•Cadernos de Saude Publica•2000•References: 3

    Foram descritas as atividades do farmacêutico especialista em informação sobre medicamentos (IM) e caracterizados os Centros de Informação sobre Medicamentos (CIMs), deixando claro o que não são e o que são - mitos e fatos. Foram apresentadas as definições de IM e de CIMs e apresentadas as atividades usuais dos Centros, destacando a informação passiva como atividade fundamental. Foi apresentado o Sistema Brasileiro de Informação sobre Medicamento…

No prominent works on this page.

  • Sistema Brasileiro de Informação sobre Medicamentos - Sismed

    Open Access•Carlos C F Vidotti, Rogério Hoefler et al.•ARTICLE•Cadernos de Saude Publica•2000•References: 3

    Foram descritas as atividades do farmacêutico especialista em informação sobre medicamentos (IM) e caracterizados os Centros de Informação sobre Medicamentos (CIMs), deixando claro o que não são e o que são - mitos e fatos. Foram apresentadas as definições de IM e de CIMs e apresentadas as atividades usuais dos Centros, destacando a informação passiva como atividade fundamental. Foi apresentado o Sistema Brasileiro de Informação sobre Medicamento…

  • P1-282 Sublingual misoprostol for preventing postpartum haemorrhage: A systematic review

    Rogério Hoefler, M Silva et al.•ARTICLE•Journal of Epidemiology and…•2011

    Objective To assess the efficacy and safety of sublingual misoprostol for preventing postpartum haemorrhage. Method MEDLINE, Embase, CRD, CENTRAL, mRCT, LILACS, SciELO, ProQuest and ISI Web of Knowledge databases were searched. There were no language, accessibility, or publication date restrictions. Randomised clinical trials of sublingual misoprostol in comparison with placebo or other uterotonics were eligible. The primary outcome was postpartu…

  • Added therapeutic value of new drugs approved in Brazil from 2004 to 2016

    Open Access•Rogério Hoefler, Teresa Leonardo Alves et al.•ARTICLE•Cadernos de Saude Publica•2019•References: 18

    This study aimed to assess the level of therapeutic innovation of new drugs approved in Brazil over 13 years and whether they met public health needs. Comparative descriptive analysis of therapeutic value assessments performed by the Brazilian Chamber of Drug Market Regulation (CMED) and the French drug bulletin Prescrire for new drugs licensed in Brazil, from January 1st 2004 to December 31st 2016. The extent to which new drugs met public health…

Alternative medicine (3 works) · Medicine (3 works) · Internal Medicine (2 works) · Internal Medicine (2 works) · Anesthesia (1 works) · Approved drug (1 works) · Business (1 works) · Computer Science (1 works) · Disease (1 works) · Drug (1 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae